FindMyRecallSubscribe
Class I: serious health riskTerminated

Blue Square Market LiDa DAIDAIHUA Recall

LiDa DAIDAIHUA (also packaged as LiDa DAIDAIHUAJIAONANG), capsules, packaged in 1

Blue Square Market, Inc. · North Huntingdon, PA

Risk level
Class I
Reported by FDA
Nov 25, 2015
Recall ID
D-0296-2016
Check your lot numberHow we source this data

Summary

Blue Square Market recalled LiDa DAIDAIHUA starting Aug 6, 2015. The FDA classified it as Class I (serious health risk) and published enforcement report D-0296-2016 on Nov 25, 2015. Reason: Marketed Without An Approved NDA/ANDA: presence of undeclared Sibutramine and Phenolphthalein. Status: Terminated.

Why it was recalled

Marketed Without An Approved NDA/ANDA: presence of undeclared Sibutramine and Phenolphthalein.

Product description

LiDa DAIDAIHUA (also packaged as LiDa DAIDAIHUAJIAONANG), capsules, packaged in 1.6oz box 30 capsules per box, Kunming Dali Industry & Trade Co., Ltd

Lot numbers, UPCs & expiration codes

all lots

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0296-2016
Classification
Class I
Status
Terminated
Recall initiated
Aug 6, 2015
FDA report date
Nov 25, 2015
Quantity
25 boxes
Recall type
Voluntary: Firm initiated
Recalling firm
Blue Square Market, Inc.

Original FDA data

Every field from FDA enforcement report D-0296-2016, exactly as published.

Show all FDA fields
City
North Huntingdon
State
PA
Status
Terminated
Country
United States
Event ID
71912
Address
2021 Clay Pike
Address (line 2)
Suite 1
Code information
all lots
Postal code
15642-6319
Report date
Nov 25, 2015
Product type
Drugs
Recall number
D-0296-2016
Classification
Class I
Recalling firm
Blue Square Market, Inc.
Product quantity
25 boxes
Termination date
Oct 18, 2018
Reason for recall
Marketed Without An Approved NDA/ANDA: presence of undeclared Sibutramine and Phenolphthalein.
Voluntary / mandated
Voluntary: Firm initiated
Product description
LiDa DAIDAIHUA (also packaged as LiDa DAIDAIHUAJIAONANG), capsules, packaged in 1.6oz box 30 capsules per box, Kunming Dali Industry & Trade Co., Ltd
Distribution pattern
Nationwide
Recall initiation date
Aug 6, 2015
Initial firm notification
Press Release
Center classification date
Nov 17, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0296-2016, published Nov 25, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls